Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)
Abstract
Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are the most common leukemias of the elderly (>43 year). However, the sequential occurrence of CML followed by CLL in the same patient is extremely rare. In our report, a 52-year-old female was diagnosed with CLL (type of bone marrow (BM) infiltration was nodular and interstitial) and was treated with chlorambucil. 64 months after the diagnosis of CLL, she developed CML. She was treated with imatinib (400mg/day). After a few months, signs of CML were disappeared and CLL became dominant. This is first reported case.
Bhagavathi S, Borromeo V, Desai H, Crisan D. Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia. Ann Clin Lab Sci. 2008 Autumn;38(4):405- 9.
Esteve J, Cervantes F, Rives S, Rozman M, Zarco MA, Montserrat E. simultaneous occurrence of b-cell chronic lymphocytic leukemia and chronic myeloid leukemia with further evolution to lymphoid blast crisis. Haematologica. 1997; 82:596-599.
Campregher PV, Hamerschlak N. Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice. Clin Lymphoma Myeloma Leuk. 2013 Dec 30.
Jia L, Clear A, Liu FT, Matthews J, Uddin N, McCarthy A, et al. Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia. Blood. 2014 Mar 13;123(11):1709-19.
Hattori H, Kuwayama M, Kotake T, Karasuno T. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia]. Gan To Kagaku Ryoho. 2011 Feb;38(2):333-6.
Nagao T, Takahashi N, Kameoka Y, Noguchi S, Shinohara Y, Ohyagi H, et al. Dasatinibresponsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia. Intern Med. 2013;52(22):2567-71.
Chang H, Sutherland R, Nayar R, Li D, Kamel-Reid S, Mile MA, et al. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence- activated cell sorting . Cancer Genet Cytogenet. 2004 Jul 15;152(2):146-8.
Jurdi A, Krishnan K, Chakraborty K. A ‘double-hit’ bone marrow rare co-occurrence of 2 diferent pathologies. 2014 Jan;12(1).
Emilia G, Marasca R, Zucchini P, Temperani P, Luppi M, Torelli G, et al. BCR-ABL rearrangement is not detectable in essential thrombocythemia. Blood. 2001; 97: 2187-2189.
Kermani IA, Dehdilani M, Dolatkhah R. Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin. Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):367-71.
Chen Y, Li S. Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia. Onco Targets Ther. 2014 Jan 31;7:177-186.
D'Arena G, Gemei M, Luciano L, D'Auria F, Deaglio S, Statuto T, et al. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment? J Clin Oncol. 2012 Nov 10;30(32):e327-30.
Buda-Okreglak EM, Cordaro DV. Simultaneous chronic myeloid leukemia and chronic lymphocytic leukemia. Blood. 2011 May 19;117(20):5279.
Katović SK, Vasilj A, Maricević I, Carzavec D, Jurić SC. Simultaneous occurrence of chronic lymphocytic and chronic myeloid leukemia. Coll Antropol. 2010 Jun;34(2):653-5.
Gozzetti A, Bocchia M, Crupi R, Calabrese S, Pirrotta MT, Raspadori D, et al. Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics. Cancer Genet Cytogenet. 2008 Jan 1;180(1):83-4.
Rahman K, George S, Mangal S, Mehata A.Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case. Indian J Pathol Microbiol. 2013 Oct-Dec;56(4):453-6.
Sterkers Y, Preudhomme C, Laï JL, Demory JL, Caulier MT, Wattel E, et al. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood. 1998 Jan;91(2):616-22.
Salmelin C, Vilpo J. Chlorambucil-induced high mutation rate and suicidal gene downregulation in a base excision repair-deficient Escherichia coli strain. Mutat Res. 2002 Mar 20;500(1-2):125-34.
Russell LB, Hunsicker PR, Cacheiro NL, Bangham JW, Russell WL, Shelby MD. Chlorambucil effectively induces deletion mutations in mouse germ cells. Proc Natl Acad Sci U S A. 1989 May;86(10):3704-8.
Scrideli CA, de Oliveira FM, Brassesco MS, de Paula Queiroz R, Bernardes JE, Valera ET, et al. Is p190 bcr- abl rearrangement necessary for acute transformation in some p210 CML of childhood? Leuk Res. 2009 Mar;33(3):495-9.
Pangalis GA, Roussou PA, Kittas C, Mitsoulis- Mentzikoff C, Matsouka-Alexandridis P, Anagnostopoulos N, et al. Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non- Hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis. Cancer. 1984 Aug 15;54(4):702-8.
| Files | ||
| Issue | Vol 8, No 4 (2014) | |
| Section | Articles | |
| Keywords | ||
| Chronic lymphocytic leukemia Chronic myeloid leukemia Dry tap | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
